To overcome the barriers to lung cancer treatment efficacy, a novel nanotechnology-based therapeutic strategy—nanoPDLIM2—has been developed to restore PDLIM2 expression in tumors. This evidence concerns the gene PDLIM2 and lung carcinoma.